Financial Statement Analysis for Glaxosmithkline Bangladesh Limited
List of Graphs [pic]
Figure 1: Analysis of Sales Revenue 2010 9
Figure 2: Analysis of Sales Revenue 2011 10
Figure 3: Analysis of Sales Revenue 2012 10
Figure 4: Current ratio 16
Figure 5: Acid/Test Quick Ratio 17
Figure 6: Profit margin Ratio 18
Figure 7: Asset turnover 19
Figure 8: return on asset 19
Figure 9: Return on shareholders equity 20
Figure 10: Earning per share (EPS) 21
Figure 11: Price/Earning (P/E) ratio 22
Figure 12: Price/Equity ratio 22
Figure 13: Dividend per share (DPS) 23
Figure 14: Debt to total asset ratio 24
Figure 15: Net assets value per share 25
Figure 16: Market price per share 27
List of Tables [pic]
Table 1: Analysis of Sales Revenue 10
Table 2: Shareholding Information 11
Table 3: Shareholders equity 17
Table 4: Financial Performance 25
Table 5: Appropriation of Profit 26
Executive Review [pic]
In the era of competition, to achieve the economic strength, a firm must run smoothly, effectively and efficiently. Adaptation of proper performance evolution criteria is an essential precondition for that. Proper performance measurement criteria can detect the strength and weakness of the firm. Moreover, with proper design of a plan, it is possible to reduce the weakness and to utilize the strength of the firm whose ultimate result is to achieve the economic goal. The financial analysis is the proper way to measure the actual performance and to detect the cause & effect of relationship related to performance measurement as well as to detect strength and weakness of the firm.
The main objective of this research project is to understand all four financial statements and see how they are used for practical purposes by different types of users. To achieve that objective we studied a world renowned corporation, annual report of GlaxoSmithKline Bangladesh Limited from 2010 to 2012.
Introduction [pic]
Every business
Figure 1: Analysis of Sales Revenue 2010 9
Figure 2: Analysis of Sales Revenue 2011 10
Figure 3: Analysis of Sales Revenue 2012 10
Figure 4: Current ratio 16
Figure 5: Acid/Test Quick Ratio 17
Figure 6: Profit margin Ratio 18
Figure 7: Asset turnover 19
Figure 8: return on asset 19
Figure 9: Return on shareholders equity 20
Figure 10: Earning per share (EPS) 21
Figure 11: Price/Earning (P/E) ratio 22
Figure 12: Price/Equity ratio 22
Figure 13: Dividend per share (DPS) 23
Figure 14: Debt to total asset ratio 24
Figure 15: Net assets value per share 25
Figure 16: Market price per share 27
List of Tables [pic]
Table 1: Analysis of Sales Revenue 10
Table 2: Shareholding Information 11
Table 3: Shareholders equity 17
Table 4: Financial Performance 25
Table 5: Appropriation of Profit 26
Executive Review [pic]
In the era of competition, to achieve the economic strength, a firm must run smoothly, effectively and efficiently. Adaptation of proper performance evolution criteria is an essential precondition for that. Proper performance measurement criteria can detect the strength and weakness of the firm. Moreover, with proper design of a plan, it is possible to reduce the weakness and to utilize the strength of the firm whose ultimate result is to achieve the economic goal. The financial analysis is the proper way to measure the actual performance and to detect the cause & effect of relationship related to performance measurement as well as to detect strength and weakness of the firm.
The main objective of this research project is to understand all four financial statements and see how they are used for practical purposes by different types of users. To achieve that objective we studied a world renowned corporation, annual report of GlaxoSmithKline Bangladesh Limited from 2010 to 2012.
Introduction [pic]
Every business